MedPath

Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage

Not Applicable
Completed
Conditions
Lymphedema
Registration Number
NCT01096589
Lead Sponsor
Solventum US LLC
Brief Summary

Objectives. The primary objective of the study is to assess volume reduction in the treatment of lymphoedematous legs and arms with compression bandaging.

Secondary objectives:

* Assessment of safety

* Quality of life

* Health economic parameters

* Slippage

* Subbandage pressure

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
82
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percent Volume Change of Affected Limb at End of Treatment Compared to Baseline.baseline and after 3 weeks of treatment
Secondary Outcome Measures
NameTimeMethod
Assessment of Safety by Incidence of Adverse Events.3 weeks

Trial Locations

Locations (11)

NorthShore University Healthsystem

🇺🇸

Evanston, Illinois, United States

University of Missouri

🇺🇸

Columbia, Missouri, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Memorial Hermann Hyperbaric Center

🇺🇸

Houston, Texas, United States

56 London Road Clinic

🇬🇧

Milborne Port, Dorset, United Kingdom

Kendal Lymphology Centre

🇬🇧

Kendal, United Kingdom

LOROS Hospice

🇬🇧

Leicester, United Kingdom

St Giles Hospice Lymphoedema Service

🇬🇧

Lichfield, United Kingdom

Enfield Macmillan Lymphoedema Service

🇬🇧

London, United Kingdom

St Oswalds Hospice Lymphoedema Clinic

🇬🇧

Newcastle-upon-Tyne, United Kingdom

Scroll for more (1 remaining)
NorthShore University Healthsystem
🇺🇸Evanston, Illinois, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.